Journal of Diabetes Research
Scope & Guideline
Leading the way in diabetes research and innovation.
Introduction
Aims and Scopes
- Diabetes Pathophysiology and Mechanisms:
Research exploring the underlying biological mechanisms of diabetes, including insulin resistance, beta-cell dysfunction, and genetic factors influencing disease progression. - Clinical Management and Treatment Strategies:
Studies evaluating various treatment modalities for diabetes, including pharmacological interventions, lifestyle modifications, and emerging therapies such as GLP-1 receptor agonists and SGLT-2 inhibitors. - Diabetes Complications:
Research focused on the complications associated with diabetes, such as cardiovascular disease, diabetic retinopathy, nephropathy, and neuropathy, and their management. - Public Health and Epidemiology:
Investigations into the epidemiology of diabetes, including prevalence, risk factors, and the impact of diabetes on public health, particularly in diverse populations. - Innovative Technologies in Diabetes Management:
Studies that assess the application of new technologies, such as continuous glucose monitoring and telemedicine, in improving diabetes care and patient outcomes. - Nutritional and Lifestyle Interventions:
Research examining the role of diet, physical activity, and behavioral interventions in diabetes prevention and management. - Integrative and Traditional Medicine Approaches:
Exploration of complementary and alternative medicine approaches, including traditional Chinese medicine, in the treatment of diabetes.
Trending and Emerging
- Diabetes and COVID-19 Interactions:
Research examining the relationship between diabetes and COVID-19, including the impact of diabetes on disease severity and outcomes, has gained significant traction in response to the pandemic. - Precision Medicine and Genomics:
Studies focusing on the genetic and genomic aspects of diabetes, including personalized medicine approaches that tailor treatment based on individual genetic profiles, are increasingly prevalent. - Machine Learning and Artificial Intelligence:
The application of machine learning and AI in predicting diabetes outcomes, optimizing treatment regimens, and enhancing patient monitoring is an emerging area of focus, reflecting the integration of technology in healthcare. - Behavioral Health and Diabetes Distress:
There is a growing emphasis on the psychological aspects of diabetes management, including diabetes distress and the impact of mental health on treatment adherence and outcomes. - Microbiome and Diabetes:
Research exploring the gut microbiome's role in diabetes pathogenesis and management is on the rise, highlighting the importance of microbiota in metabolic health. - Telemedicine and Remote Patient Monitoring:
The advancement and implementation of telehealth solutions for diabetes management have gained momentum, especially post-pandemic, emphasizing the need for accessible healthcare solutions.
Declining or Waning
- Basic Science Research:
There has been a noticeable decrease in basic science studies that solely focus on cellular and molecular mechanisms of diabetes without direct clinical implications. This shift may be due to an increasing emphasis on translational research that bridges laboratory findings with clinical applications. - Historical Epidemiological Studies:
Research that reviews historical data or trends in diabetes prevalence and outcomes appears to be waning. This could be attributed to a shift towards more contemporary, real-time data analysis and the need for immediate applicability in clinical settings. - Pharmacotherapy Comparisons:
Comparative studies of older diabetes medications are becoming less frequent as newer agents and combination therapies gain prominence in diabetes management discussions. - Conventional Dietary Interventions:
Studies focusing solely on traditional dietary interventions without incorporating modern nutritional science or technology are becoming less common, as there's a trend towards personalized nutrition and integrative approaches.
Similar Journals
DIABETES & METABOLISM
Pioneering Research in Endocrinology and BeyondDIABETES & METABOLISM, published by MASSON EDITEUR in France, is a leading academic journal dedicated to the fields of endocrinology, diabetes, and metabolism. With an impressive Impact Factor reflecting its esteemed reputation, the journal has been ranked in the Q1 category across multiple disciplines including Endocrinology, Internal Medicine, and more, showcasing its significance and influence in the scientific community. Since its inception in 1996 and continuing its contributions through 2024, DIABETES & METABOLISM systematically disseminates high-quality research findings, reviews, and clinical studies aimed at furthering knowledge and encouraging innovation in metabolic diseases. Although not an open-access journal, it ensures that valuable research is accessible to a broad audience through institutional subscriptions and affiliations. As a key resource for researchers, clinicians, and students alike, this journal stands at the forefront of advancing understanding and treatment options in diabetes and related metabolic disorders, making it an essential addition to any academic library.
Current Diabetes Reports
Exploring the complexities of diabetes for a brighter future.Current Diabetes Reports is a leading academic journal published by CURRENT MEDICINE GROUP, dedicated to advancing research and clinical practices in the field of diabetes and endocrinology. With an impressive impact factor and ranked in the prestigious Q1 category for both Endocrinology, Diabetes and Metabolism and Internal Medicine, this journal serves as a vital resource for researchers, clinicians, and students alike. Established in 2001 and converging years up to 2024, Current Diabetes Reports aims to disseminate high-quality, peer-reviewed research articles, reviews, and clinical studies that address the multifaceted challenges of diabetes management and treatment. As it continues to thrive within a robust international community, the journal provides critical insights that are essential for improving patient outcomes and informing public health policies in the United States and beyond.
ACTA DIABETOLOGICA
Championing Excellence in Endocrinology ResearchACTA DIABETOLOGICA, published by SPRINGER-VERLAG ITALIA SRL, is a distinguished peer-reviewed journal dedicated to the rapidly evolving fields of endocrinology, diabetes, and metabolism. With an impressive convergence of research from 1991 to 2024, it is recognized for its significant contributions, boasting a Q1 ranking in Internal Medicine and Q2 rankings in Endocrinology categories as of 2023. Its Scopus rankings further highlight its impact, placing it in the 81st percentile in Internal Medicine. The journal serves as a vital platform for professionals and researchers, facilitating the dissemination of innovative findings and fostering a comprehensive understanding of metabolic disorders. Although the journal is not open access, it remains an essential resource, ensuring high visibility and accessibility of critical research to its scholarly audience.
British Journal of Diabetes
Empowering healthcare professionals with cutting-edge insights.The British Journal of Diabetes, published by the Association of British Clinical Diabetologists, is a premier journal dedicated to advancing the understanding, prevention, and management of diabetes. With an ISSN of 2397-6233, this journal aims to disseminate high-quality research findings, clinical studies, and reviews that address the complexities of diabetes care and research. While currently not available as an open access option, the journal is committed to enhancing the visibility of cutting-edge diabetes research for healthcare professionals and academics. Located in the heart of England, this journal plays a crucial role in bridging the gap between clinical practice and research innovation, making it an essential resource for practitioners, researchers, and students alike. The British Journal of Diabetes is determined to contribute significantly to the global dialogue on diabetes, as it covers a wide spectrum of topics from epidemiology and public health to novel therapeutic strategies and patient management approaches.
Diabetes & Metabolism Journal
Transforming diabetes research into actionable insights.Diabetes & Metabolism Journal, published by the Korean Diabetes Association, is a leading open-access journal dedicated to advancing the field of endocrinology, with a specific focus on diabetes and metabolism. Since its establishment in 1991, the journal has provided a robust platform for disseminating high-quality research, contributing significantly to our understanding of diabetes pathophysiology, treatment, and prevention strategies. The journal boasts an impressive impact factor, ranking in the top quartile (Q1) of its category and occupying the 28th position out of 244 in Scopus rankings, which places it in the 88th percentile among its peers. With its commitment to open access, researchers, professionals, and students globally can explore the latest findings and innovative solutions in diabetes research. The journal continues to serve as an essential resource for those dedicated to improving patient outcomes and advancing scientific knowledge in the metabolic disorders domain.
BMJ Open Diabetes Research & Care
Connecting researchers and clinicians for better diabetes outcomes.BMJ Open Diabetes Research & Care is a premier open access journal published by the BMJ PUBLISHING GROUP, dedicated to advancing the field of diabetes research and care. With an impressive impact factor and positioned in the Q1 category of Endocrinology, Diabetes and Metabolism, this journal serves as a vital resource for researchers, clinicians, and healthcare professionals striving to improve diabetes management and treatment strategies. Since its inception in 2014, the journal has provided an accessible platform for high-quality, peer-reviewed research, ensuring global outreach and dissemination of groundbreaking findings in diabetes care. With Scopus ranking it at #35 out of 244 in its field, reflecting an 85th percentile ranking, BMJ Open Diabetes Research & Care remains committed to fostering innovation and discourse within the diabetes community. This journal not only publishes original research articles but also invites systematic reviews, clinical studies, and comprehensive reviews, aiming to address the pressing challenges faced in diabetes care today.
DIABETIC MEDICINE
Empowering clinicians with cutting-edge insights in diabetes care.DIABETIC MEDICINE is a leading peer-reviewed journal published by Wiley, dedicated to advancing the field of endocrinology, specifically focusing on the pathophysiology, management, and prevention of diabetes mellitus and its complications. With an impressive impact factor reflecting its significant role in shaping clinical practice and research, DIABETIC MEDICINE holds a prominent position among its peers, categorized in the Q1 quartiles for Endocrinology, Diabetes and Metabolism, and Internal Medicine. Since its inception in 1984, the journal has provided a platform for rigorous and innovative research, fostering collaborative efforts among researchers, clinicians, and students to enhance diabetes care. The journal is esteemed for its high-ranking performance in Scopus, highlighted by its ranking of #33 in Internal Medicine and #64 in Endocrinology, Diabetes, and Metabolism. By offering insightful access to groundbreaking studies and reviews, DIABETIC MEDICINE plays a crucial role in informing policy and improving medical outcomes for individuals with diabetes, making it an essential resource for those in medical and clinical research fields.
Journal of Diabetology
Transforming the landscape of diabetes understanding.The Journal of Diabetology, published by Wolters Kluwer Medknow Publications, is a premier platform dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Since its inception in 2010, this Open Access journal has provided researchers and healthcare professionals with a wealth of knowledge through rigorous peer-reviewed articles that cover clinical research, epidemiology, and innovative treatment strategies. With an E-ISSN of 2078-7685 and a commitment to disseminating high-quality scientific work, the journal plays a pivotal role in contributing to the global discourse on diabetes care and prevention. Its dedication to accessibility enhances its impact on both established scholars and emerging researchers seeking to make meaningful contributions in the field. By fostering a collaborative environment, the Journal of Diabetology aims to bridge the gap between research and practical implementation, ultimately improving outcomes for individuals affected by diabetes.
CURRENT DIABETES REVIEWS
Fostering Collaboration in Diabetes ResearchCURRENT DIABETES REVIEWS is a leading academic journal published by Bentham Science Publishers Ltd, dedicated to disseminating high-quality reviews and cutting-edge insights in the field of Endocrinology, Diabetes and Metabolism. Established in 1996 and actively publishing from 2005 to 2024, this journal holds a prestigious position within the academic community, evidenced by its Q2 ranking in both relevant categories for 2023 and its impactful presence in Scopus, where it ranks #83 out of 244 in Endocrinology and Diabetes and Metabolism. Despite being a subscription-based journal, it provides researchers, healthcare professionals, and students with valuable contributions that significantly advance the understanding of diabetes and related metabolic disorders. With a commitment to promoting interdisciplinary collaboration and innovation, CURRENT DIABETES REVIEWS serves as an essential resource for those seeking to stay abreast of the latest developments in diabetes research and therapies.
Diabetes Mellitus
Fostering collaboration in the fight against diabetes.Diabetes Mellitus, published by the Endocrinology Research Centre in the Russian Federation, is an esteemed open-access journal dedicated to the field of endocrinology, diabetes, and metabolism. Since its inception in 1998, this journal has been a pivotal platform for disseminating cutting-edge research and comprehensive reviews that address the multifaceted challenges posed by diabetes. With its current quartile ranking of Q4 in Endocrinology and the associated fields, as well as commendable involvement in the broader scope of Internal Medicine, Diabetes Mellitus plays a crucial role in enhancing clinical practices and informing innovative therapeutic strategies. The journal caters to a diverse audience of researchers, healthcare professionals, and students, particularly those seeking to expand their knowledge and improve patient outcomes in diabetes care. With a commitment to fostering scientific conversation and collaboration, Diabetes Mellitus is an invaluable resource for anyone engaged in the fight against diabetes and its complications.